Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.04.2023 | Case report

Cotrimoxazole/rituximab

Pneumocystis jirovecii pneumonia and acute kidney injury: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bromley K, et al. Hypercalcaemia in an immunocompromised patient: consider Pneumocystis jirovecii pneumonia. Medical Journal of Australia 217: 517-518, No. 10, 21 Nov 2022. Available from: URL: https://www.mja.com.au Bromley K, et al. Hypercalcaemia in an immunocompromised patient: consider Pneumocystis jirovecii pneumonia. Medical Journal of Australia 217: 517-518, No. 10, 21 Nov 2022. Available from: URL: https://​www.​mja.​com.​au
Metadaten
Titel
Cotrimoxazole/rituximab
Pneumocystis jirovecii pneumonia and acute kidney injury: case report
Publikationsdatum
01.04.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-37587-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Liraglutide

Case report

Elasomeran

Case report

Canagliflozin

Case report

Antineoplastics

Case report

Eribulin